positiveSYS.SOURCE: FDA• 2026-07-19T02:40:22Z

FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults

#cholesterol #fda #pharmaceuticals

The FDA has approved the first oral PCSK9 inhibitor designed to lower LDL cholesterol in adults with high cholesterol. This marks a significant advancement in cardiovascular treatment options, offering a new therapeutic approach for managing cholesterol levels.

Read original article

*** END OF TRANSMISSION ***

> GCC AND CLANG NON-COMPLIANCE WITH STANDARD C++ LANGUAGE LINKAGE RULES > HMD TOUCH 4G HYBRID SMARTPHONE WITH CLOUD SERVICES AND 4G LTE > EXPIRATION OF THE FINAL MPEG-4 VISUAL PATENT MARKING THE END OF A LEGACY CODEC ERA > TEXAS POLICE ALLOCATE $4.5 MILLION FOR MILITARY-GRADE SURVEILLANCE CHEVY TAHOES > REGULATORY CONFLICTS IN AUTONOMOUS VEHICLE POLICY DEVELOPMENT > KIMI K3 EXCEEDS CAPACITY, MOONSHOT AI TEMPORARILY HALTS NEW SUBSCRIPTIONS > C64 BASIC DUNGEON CRAWLER DEVELOPMENT: GOBLIN MOVEMENT AND KEY REDEFINITION IN PART 8 > CHRISTOPHER NOLAN CRITICIZES AI AS 'TROJAN HORSE' IN TECHCRUNCH INTERVIEW > COST-EFFECTIVE ESP32-BASED SYSTEM REPLACES EXPENSIVE BOWLING CENTER INFRASTRUCTURE > TERENCE MCKENNA'S 1988-1989 PSILOCYBIN CRISIS AND ITS IMPACT ON HIS PSYCHEDELIC PHILOSOPHY> GCC AND CLANG NON-COMPLIANCE WITH STANDARD C++ LANGUAGE LINKAGE RULES > HMD TOUCH 4G HYBRID SMARTPHONE WITH CLOUD SERVICES AND 4G LTE > EXPIRATION OF THE FINAL MPEG-4 VISUAL PATENT MARKING THE END OF A LEGACY CODEC ERA > TEXAS POLICE ALLOCATE $4.5 MILLION FOR MILITARY-GRADE SURVEILLANCE CHEVY TAHOES > REGULATORY CONFLICTS IN AUTONOMOUS VEHICLE POLICY DEVELOPMENT > KIMI K3 EXCEEDS CAPACITY, MOONSHOT AI TEMPORARILY HALTS NEW SUBSCRIPTIONS > C64 BASIC DUNGEON CRAWLER DEVELOPMENT: GOBLIN MOVEMENT AND KEY REDEFINITION IN PART 8 > CHRISTOPHER NOLAN CRITICIZES AI AS 'TROJAN HORSE' IN TECHCRUNCH INTERVIEW > COST-EFFECTIVE ESP32-BASED SYSTEM REPLACES EXPENSIVE BOWLING CENTER INFRASTRUCTURE > TERENCE MCKENNA'S 1988-1989 PSILOCYBIN CRISIS AND ITS IMPACT ON HIS PSYCHEDELIC PHILOSOPHY